+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Medical Simulation Market by Product & Service, Fidelity, and End User: Global Opportunity Analysis and Industry Forecast, 2018-2025

  • ID: 4828636
  • Report
  • Region: Global
  • 216 pages
  • Allied Analytics LLP
1 of 3
Medical simulation is the virtual duplication of in situ activities or phenomenon, representing the functions and properties of a selective real abstract or process. It is used to train healthcare professionals using advanced healthcare technologies.

The global medical simulation market was valued at $1,132 million in 2017 and is estimated to reach $ 3,251 million by 2025, registering a CAGR of 14.0% from 2018 to 2025. The global medical simulation market is driven by the increase in use of simulation in healthcare, rise in deaths due to medical errors, and necessity to improve patient safety outcomes. Moreover, the benefits of medical simulation such as training of complex as well as normal cases for professionals and technological advancements in medical field further increase the demand for medical simulation. However, high installation cost and lack of complete real situation restrain the market growth.

The global medical simulation market is segmented based on product & service, fidelity, end user, and region. Based on product & service, it is divided into model-based simulation, web-based simulation, and simulation training services. Model-based simulation is further classified into patient simulation, surgical simulation, and ultrasound simulation. Patient simulation is segmented into task trainers, manikin-based simulators, and standardized patient simulators. Surgical simulation is sub-segmented in laparoscopic surgical simulators, arthroscopic surgical simulators, cardiovascular simulators, gynecology simulators, and others. Web-based simulation segment is classified into simulation software, performance-recording software, and virtual tutors. Simulation training services comprise vendor-based training services, custom consulting services, and educational society services. Based on fidelity, the market is classified into low-fidelity, medium fidelity, and high-fidelity simulators. Based on end user, the market is divided into academic institutions & research centers, hospitals & clinics, and military organizations. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
  • This report provides an extensive analysis of the emerging trends and dynamics in the global medical simulation market.
  • This study provides the landscape of the global market to predict the competitive environment across geographies.
  • This report entails the detailed quantitative analyses of the current trends and future estimations to identify the prevailing opportunities.
  • Comprehensive analyses of factors that drive and restrict the market growth is provided in the report.
  • Region- and country-wise analysis is conducted to understand the market trends and dynamics.
KEY MARKET SEGMENTS
  • By Product & Service
o Model-based Simulation
  • Patient Simulation
  • Task Trainer Simulation
  • Manikin-based Simulation
  • Standardized Patient Simulation
  • Surgical Simulation
  • Laparoscopic Surgical Simulators
  • Arthroscopic Surgical Simulators
  • Cardiovascular Simulators
  • Gynecology Simulators
  • Others
  • Ultrasound Simulation
o Web-based Simulation
  • Simulation Software
  • Performance-Recording Software
  • Virtual Tutors
o Simulation Training Services
  • Vendor-based Training
  • Custom Consulting Services
  • Educational Societies
  • By Fidelity
o Low-fidelity
o Medium-fidelity
o High-fidelity
  • By End User
o Academic Institutions & Research Centers
o Hospitals & Clinics
o Military Organizations
  • By Region
o North America
  • U.S.
  • Canada
  • Mexico
o Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
o Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
o LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
The key players profiled in this report are as follows:
  • Laerdal Medical AS
  • CAE, Inc.
  • 3D Systems, Inc.
  • Simulab Corporation
  • Simulaids, Inc.
  • Limbs and Things, Ltd.
  • Kyoto Kagaku Co. Ltd.
  • Mentice AB
  • Surgical Science Sweden AB
  • Gaumard Scientific Company, Inc.
The other players operating in the medical simulation market include (not profiled in the report)
  • MSC
  • 3-Dmed
  • HRV
  • Medical Simulation Technologies sp. z o.o.
  • Remedy Simulation Group
  • MEDICAL-X
Note: Product cover images may vary from those shown
2 of 3
CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. Market share analysis, 2018
3.4. Market dynamics

3.4.1. Impact analyses
3.4.2. Drivers

3.4.2.1. Low expenditure on healthcare
3.4.2.2. Assured improvement in patient safety outcomes
3.4.2.3. Benefits of medical simulation
3.4.2.4. Technological advancements in medical field

3.4.3. Restraints

3.4.3.1. High cost of setting up simulators
3.4.3.2. Limitation of a complete real situation

3.4.4. Opportunities

3.4.4.1. Lucrative opportunities in emerging markets

CHAPTER 4: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE

4.1. Overview

4.1.1. Market size and forecast

4.2. Model-based simulation

4.2.1. Market size and forecast by type

4.2.1.1. Patient simulation

4.2.1.1.1. Market size and forecast

4.2.1.1.1.1. Task trainer simulation: Market Size and Forecast
4.2.1.1.1.2. Manikin-based simulation: Market Size and Forecast
4.2.1.1.1.3. Standardized Patient Simulation: Market Size and Forecast

4.2.1.2. Surgical simulation

4.2.1.2.1. Market size and forecast

4.2.1.2.1.1. Laparoscopic Surgical Simulators: Market Size and Forecast
4.2.1.2.1.2. Arthroscopic Surgical Simulators: Market Size and Forecast
4.2.1.2.1.3. Cardiovascular Simulators: Market Size and Forecast
4.2.1.2.1.4. Gynecology Simulators: Market Size and Forecast
4.2.1.2.1.5. Others: Market Size and Forecast

4.2.1.3. Ultrasound simulation

4.2.1.3.1. Market size and forecast

4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country

4.3. Web-based simulation

4.3.1. Market size and forecast by type

4.3.1.1. Simulation Software: Market Size and Forecast
4.3.1.2. Performance Recording Software: Market Size and Forecast
4.3.1.3. Virtual Tutors: Market Size and Forecast

4.3.2. Market size and forecast by region
4.3.3. Market analysis, by country

4.4. Simulation Training Services

4.4.1. Market size and forecast by type

4.4.1.1. Vendor-based Training: Market Size and Forecast
4.4.1.2. Custom Consulting Services: Market Size and Forecast
4.4.1.3. Educational Societies: Market Size and Forecast

4.4.2. Market size and forecast by region
4.4.3. Market analysis, by country

CHAPTER 5: MEDICAL SIMULATION MARKET, BY FIDELITY

5.1. Overview

5.1.1. Market size and forecast

5.2. Low-fidelity

5.2.1. Market size and forecast by region
5.2.2. Market analysis, by country

5.3. Medium-fidelity

5.3.1. Market size and forecast by region
5.3.2. Market analysis, by country

5.4. High-fidelity

5.4.1. Market size and forecast by region
5.4.2. Market analysis, by country

CHAPTER 6: MEDICAL SIMULATION MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Academic Institutions & Research Centers

6.2.1. Market size and forecast by region
6.2.2. Market analysis, by country

6.2.2.1. Medical Academia: Market Size and Forecast
6.2.2.2. Nursing: Market Size and Forecast
6.2.2.3. Emergency Medical Services: Market Size and Forecast

6.3. Hospitals & Clinics

6.3.1. Market size and forecast by region
6.3.2. Market analysis, by country

6.4. Military Organizations

6.4.1. Market size and forecast by region
6.4.2. Market analysis, by country

CHAPTER 7: MEDICAL SIMULATION, BY REGION

7.1. Market size and forecast
7.2. North America

7.2.1. North America: Market Size and Forecast, by country

7.2.1.1. U.S. medical simulation: Market Size and Forecast

7.2.1.1.1. U.S. medical simulation: market size and forecast by product & service
7.2.1.1.2. U.S. medical simulation: market size and forecast by fidelity
7.2.1.1.3. U.S. medical simulation: market size and forecast by end user

7.2.1.2. Canada medical simulation: Market Size and Forecast

7.2.1.2.1. Canada medical simulation: market size and forecast by product & service
7.2.1.2.2. Canada medical simulation: market size and forecast by fidelity
7.2.1.2.3. Canada medical simulation: market size and forecast by end user

7.2.1.3. Mexico medical simulation: Market Size and Forecast

7.2.1.3.1. Mexico medical simulation: market size and forecast by product & service
7.2.1.3.2. Mexico medical simulation: market size and forecast by fidelity
7.2.1.3.3. Mexico medical simulation: market size and forecast by end user

7.2.2. North America: market size and forecast by product & service
7.2.3. North America: market size and forecast by fidelity
7.2.4. North America: market size and forecast by end user

7.3. Europe

7.3.1. Europe: Market Size and Forecast, by country

7.3.1.1. Germany medical simulation: Market Size and Forecast

7.3.1.1.1. Germany medical simulation: market size and forecast by product & service
7.3.1.1.2. Germany medical simulation: market size and forecast by fidelity
7.3.1.1.3. Germany medical simulation: market size and forecast by end user

7.3.1.2. France medical simulation: Market Size and Forecast

7.3.1.2.1. France medical simulation: market size and forecast by product & service
7.3.1.2.2. France medical simulation: market size and forecast by fidelity
7.3.1.2.3. France medical simulation: market size and forecast by end user

7.3.1.3. UK medical simulation: Market Size and Forecast

7.3.1.3.1. UK medical simulation: market size and forecast by product & service
7.3.1.3.2. UK medical simulation: market size and forecast by fidelity
7.3.1.3.3. UK medical simulation: market size and forecast by end user

7.3.1.4. Italy medical simulation: Market Size and Forecast

7.3.1.4.1. Italy medical simulation: market size and forecast by product & service
7.3.1.4.2. Italy medical simulation: market size and forecast by fidelity
7.3.1.4.3. Italy medical simulation: market size and forecast by end user

7.3.1.5. Spain medical simulation: Market Size and Forecast

7.3.1.5.1. Spain medical simulation: market size and forecast by product & service
7.3.1.5.2. Spain medical simulation: market size and forecast by fidelity
7.3.1.5.3. Spain medical simulation: market size and forecast by end user

7.3.1.6. Rest of Europe medical simulation: Market Size and Forecast

7.3.1.6.1. Rest of Europe medical simulation: market size and forecast by product & service
7.3.1.6.2. Rest of Europe medical simulation: market size and forecast by fidelity
7.3.1.6.3. Rest of Europe medical simulation: market size and forecast by end user

7.3.2. Europe: market size and forecast by product & service
7.3.3. Europe: market size and forecast by fidelity
7.3.4. Europe: market size and forecast by end user

7.4. Asia-pacific

7.4.1. Asia-pacific: Market Size and Forecast, by country

7.4.1.1. Japan medical simulation: Market Size and Forecast

7.4.1.1.1. Japan medical simulation: market size and forecast by product & service
7.4.1.1.2. Japan medical simulation: market size and forecast by fidelity
7.4.1.1.3. Japan medical simulation: market size and forecast by end user

7.4.1.2. China medical simulation: Market Size and Forecast

7.4.1.2.1. China medical simulation: market size and forecast by product & service
7.4.1.2.2. China medical simulation: market size and forecast by fidelity
7.4.1.2.3. China medical simulation: market size and forecast by end user

7.4.1.3. India medical simulation: Market Size and Forecast

7.4.1.3.1. India medical simulation: market size and forecast by product & service
7.4.1.3.2. India medical simulation: market size and forecast by fidelity
7.4.1.3.3. India medical simulation: market size and forecast by end user

7.4.1.4. Australia medical simulation: Market Size and Forecast

7.4.1.4.1. Australia medical simulation: market size and forecast by product & service
7.4.1.4.2. Australia medical simulation: market size and forecast by fidelity
7.4.1.4.3. Australia medical simulation: market size and forecast by end user

7.4.1.5. Rest of Asia-pacific medical simulation: Market Size and Forecast

7.4.1.5.1. Rest of Asia-pacific medical simulation: market size and forecast by product & service
7.4.1.5.2. Rest of Asia-pacific medical simulation: market size and forecast by fidelity
7.4.1.5.3. Rest of Asia-pacific medical simulation: market size and forecast by end user

7.4.2. Asia-pacific: market size and forecast by product & service
7.4.3. Asia-pacific: market size and forecast by fidelity
7.4.4. Asia-pacific: market size and forecast by end user

7.5. LAMEA

7.5.1. LAMEA: Market Size and Forecast, by country

7.5.1.1. Brazil medical simulation: Market Size and Forecast

7.5.1.1.1. Brazil medical simulation: market size and forecast by product & service
7.5.1.1.2. Brazil medical simulation: market size and forecast by fidelity
7.5.1.1.3. Brazil medical simulation: market size and forecast by end user

7.5.1.2. South Africa medical simulation: Market Size and Forecast

7.5.1.2.1. South Africa medical simulation: market size and forecast by product & service
7.5.1.2.2. South Africa medical simulation: market size and forecast by fidelity
7.5.1.2.3. South Africa medical simulation: market size and forecast by end user

7.5.1.3. Saudi Arabia medical simulation: Market Size and Forecast

7.5.1.3.1. Saudi Arabia medical simulation: market size and forecast by product & service
7.5.1.3.2. Saudi Arabia medical simulation: market size and forecast by fidelity
7.5.1.3.3. Saudi Arabia medical simulation: market size and forecast by end user

7.5.1.4. Rest of LAMEA medical simulation: Market Size and Forecast

7.5.1.4.1. Rest of LAMEA medical simulation: market size and forecast by product & service
7.5.1.4.2. Rest of LAMEA medical simulation: market size and forecast by fidelity
7.5.1.4.3. Rest of LAMEA medical simulation: market size and forecast by end user

7.5.2. LAMEA: market size and forecast by product & service
7.5.3. LAMEA: market size and forecast by fidelity
7.5.4. LAMEA: market size and forecast by end user

CHAPTER 8: COMPANY PROFILES

8.1. 3D SYSTEMS CORPORATION (SIMBIONIX)

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Business performance
8.1.4. Key strategic moves and developments

8.2. CAE INC.

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Key strategic moves and developments

8.3. GAUMARD SCIENTIFIC COMPANY

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Key strategic moves and developments

8.4. KYOTO KAGAKU CO. LTD.

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments

8.5. LAERDAL MEDICAL AS

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Key strategic moves and developments

8.6. LIMBS AND THINGS LTD.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Key strategic moves and developments

8.7. MENTICE AB

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Key strategic moves and developments

8.8. SIMULAB CORPORATION

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments

8.9. SIMULAIDS INC.

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Key strategic moves and developments

8.10. SURGICAL SCIENCE SWEDEN AB

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Business performance
8.10.4. Key strategic moves and developments

*Full List of Tables and Figures Available on Enquiry.

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll